News & Events
BD Board Declares Dividend
|
Contact: Colleen T. White Corporate Communications (201) 847-5369 Email: colleen_white@bd.com Patricia A. Spinella Investor Relations (201) 847-5453 Email: patricia_spinella@bd.com Franklin Lakes, NJ (January 31, 2006) -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 21.5 cents per common share. The dividend will be payable on March 31, 2006 to holders of record on March 10, 2006. The indicated annual dividend rate is 86 cents per share. About BD BD, a leading global medical technology company that makes and sells medical devices, instrumented systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs more than 25,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.
|